The use of micro-dose contraceptive at gynecological, extragenital pathology and in case of their combination
https://doi.org/10.21518/2079-701X-2019-13-50-54
Abstract
Besides the contraception the modern contraceptives have non-contraceptive effects. The ability to use the vaginal ring in patients with combined pathology as gynecological as somatic is important due to the micro-dosed of ethinyl estradiol and highly selective gestagen.
About the Authors
L. Yu. Karakhalis
Kuban State Medical University
Russian Federation
Russian Federation
Lyudmila Yu. Karakhalis, Dr. of Sci.(Med.), Professor, Professor of Chair for Obstetrics, Gynecology and Perinatology, Faculty of Continuing Education and Professional Retraining of Specialists
Krasnodar, 4, Mitrofana Sedina Str., Krasnodar, 350063
Yu. S. Ponomareva
Kuban State Medical University
Russian Federation
Russian Federation
Yuliya S. Ponomareva, a postgraduate student of Chair for Obstetrics, Gynecology and PerinatologyFaculty of Continuing Education and Professional Retraining of Specialists
Krasnodar, 4, Mitrofana Sedina Str., Krasnodar, 350063
N. S. Ivantsiv
Kuban State Medical University
Russian Federation
Russian Federation
Naira S. Ivantsiv, a postgraduate student of Chair for Obstetrics, Gynecology and Perinatology, Faculty of Continuing Education and Professional Retraining of Specialists
Krasnodar, 4, Mitrofana Sedina Str., Krasnodar, 350063
References
1. Stepanova R.N., Smolechkova N.N., Kosova A.S. Obesity a factors associate with high risk implementation preeclampsia, obstetric and peri‐neonatal complication of pregnancy (review). Uchenye zapiski Orlovskogo Gosudarstvennogo universiteta = Scientific notes of Orel state university. 2013;3:316-22. (In Russ.) Available at: http://oreluniver.ru/public/file/archive/201303.pdf.
2. Chabanova N.B., Mataev S.I., Vasilkova T.N., Shevlyukova T.P. Role of systemic inflammation in the development of pregnancy complications in obese women. Akusherstvo i Ginekologiya = Obstetrics and Gynecology. 2017;(10):12-8. (In Russ.) doi: 10.18565/aig.2017.10.12-18.
3. Marshall N.E., Guild C., Cheng Y.W., Caughey A.B., Halloran D.R. Maternal superobesity and perinatal outcomes. Am J Obstet Gynecol. 2012;206(5):417.e1-6. doi: 10.1016/j.ajog.2012.02.037.
4. Kovaleva Iu.V. Role of obesity in the development of menstrual and reproductive dysfunctions. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2014;14(2):43–51. (In Russ.) Available at: https://elibrary.ru/item.asp?id=21568180.
5. Reynolds R.M., Allan K.M., Raja E.A., Bhattacharya S., McNeill G., Hannaford P.C., Sarwar N., Lee A.J., Bhattacharya S., Norman J.E. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: followup of 1 323 275 person years. BMJ. 2013;347:4539. doi: 10.1136/bmj.f4539.
6. Maggard M.A., Yermilov I., Li Z., Maglione M., Newberry S., Suttorp M., Hilton L., Santry H.P., Morton J.M., Livingston E.H., Shekelle P.G. Pregnancy and fertility following bariatric surgery: a systematic review JAMA. 2008;300(19):2286-96. doi: 10.1001/jama.2008.641.
7. Gavrailova D. Diabetes mellitus type 2 and polycystic ovary syndrome. Vestnik po pedagogike i psikhologii Yuzhnoy Sibiri = The bulletin on pedagogics and psychology of Southern Siberia. 2014;(3):60-73. (In Russ.) Available at: https://cyberleninka.ru/article/v/diabet-2-gotipai-sindrom-polikistoznyh-yaichnikov-spkya.
8. Gafarova E.A. Clinical and laboratory manifestations of PCOS depending on phenotypic characteristics and vitamin D blood level. Prakticheskaya meditsina = Practical medicine. 2016;(1):80-84. ( In Russ.) Available at: https://cyberleninka.ru/article/n/kliniko-laboratornye-proyavleniyaspkyav-zavisimosti-ot-fenotipicheskih-osobennosteyi-urovnya-vitamina-d-v-krovi.
9. Karazhanova L.K., Zhunuspekova A.S. Hyperhomocysteinemia as a risk factor of cardiovascular diseases (Literature review). Nauka i zdravookhranenie = Science & Healthcare. 2016;(4):130-144. (In Russ.) Available at: https://cyberleninka.ru/article/n/gipergomotsisteinemiyakak-faktor-riska-serdechno-sosudistyhzabolevaniy-obzor-literatury.
10. Pasquali R., Stener-Victorin E., Yildiz B.O., Duleba A.J., Hoeger K., Mason H., Homburg R., Hickey T., Franks S., Tapanainen J.S., Balen A., Abbott D.H., Diamanti-Kandarakis E., Legro R.S. PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf). 2011;74(4):424433. doi: 10.1111/j.1365-2265.2010.03956.x.
11. Bhattacharya S., Johnson N., Tijani H.A., Hart R., Pandey S., Gibreel A.F. Female infertility. BMJ Clin Evid. 2010;2010:0819. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21406133.
12. McGovern P.G., Legro R.S., Myers E.R., Barnhart H.X., Carson S.A., Diamond M.P., Carr B.R., Schlaff W.D., Coutifaris C., Steinkampf M.P., Nestler J.E., Gosman G. Utility of screening for other causes of infertility in women with «known» polycystic ovary syndrome. Fertility and Sterility. 2006;87(2):442-444. doi: 10.1016/j.fertnstert.2006.06.050.
13. Kori M., Gov E., Arga K.Y. Molecular signatures of ovarian diseases: Insights from network medicine perspective. Syst Biol Reprod Med. 2016;62(4):26682. doi: 10.1080/19396368.2016.1197982.
14. Panay N., Palacios S., Bruyniks N., Particco M., Nappi RE5; EVES Study investigators. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Maturitas. 2019;124:55–61. doi: 10.1016/j.maturitas.2019.03.013.
15. Allen R.H., Cwiak C.A., Kaunitz A.M. Contraception in women over 40 years of age. CMAJ. 2013;185(7):565-573. doi: 10.1503/cmaj.121280.
16. Doherty D.A., Newnham J.P., Bower C., Hart R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397-1406. doi: 10.1097/AOG.0000000000000852.
17. Herguner S., Harmancı H., Herguner A., Toy H. Autistic traits in women with polycystic ovary syndrome. Res Autism Spectr Disord. 2012;6(3):1019– 1022. doi: 10.1016/j.rasd.2012.01.003.
18. Adamyan L.V., Andreeva E.N., Gasparyan S.A., Gevorkyan M.A., Grigoryan O.R., Grineva E.N., Gustovarova T.A., Dedov I.I., Demidova T.Yu., Zaydieva Ya.Z., Karakhalis L.Yu., Lizieva L.E., G.A., Sipridonova N.E., L.V., Tarasova M.A., Uvarova E.V., Filippov O.S., Khamoshina M.S., Chernukha G.E., Sheremet’eva E.V., Yarmolinskaya M.V., Soboleva E.L., Yarmolinskaya M.I. Polycystic ovary syndrome in reproductive age (Modern approaches to diagnosis and treatment). Clinical guidelines (treatment protocol). Moscow: Ministry of Health of the RF, 2015. 22 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=26714379.
19. Bezrukov A.G., Ponomarev V.V., Penzhoyan G.A., Karakhalis L.Y., Steblo E.I., Donchenko E.A. The causes of infertility, associated with external genital endometriosis and polycystic ovary syndrome. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin. 2018;25(2):29-34. (In Russ.) doi: 10.25207/1608-6228-2018-25-2-29-34.
20. Medical eligibility criteria for contraceptive use 5th ed. Geneva: World Health Organization; 2015. 14 s. Available at: https://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/en.
21. Grigorian O.R., Andreeva E.N., Dedov I.I. The influence of vaginal releasing system nuvaring on carbohydrate metabolism in women of reproductive age with diabetes mellitus type 1. Problemy reproduktsii = Russian Journal of Human Reproduction. 2013;(2):29-36. (In Russ.) Available at: https://elibrary.ru/item.asp?id=19088564.
22. Ma B., Forney L.J., Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371-89. doi: 10.1146/annurev-micro-092611-150157.
23. Luthje P., Hirschberg A.L., Brauner A. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas. 2014;77(1):32-36. doi: 10.1016/j.maturitas.2013.10.018.
24. Dobrokhotova Yu.E., Zatikyan N.G. Hormonal status and vaginal microbiocenosis. Akusherstvo, ginekologiya i reproduktsiya = Obstetrics, Gynecology and Reproduction. 2008;(3):7-9. (In Russ.) Available at: https:// www.gynecology.su/jour/article/view/208/222.
Review
For citations:
Karakhalis LY, Ponomareva YS, Ivantsiv NS. The use of micro-dose contraceptive at gynecological, extragenital pathology and in case of their combination. Meditsinskiy sovet = Medical Council. 2019;(13):50-54. (In Russ.) https://doi.org/10.21518/2079-701X-2019-13-50-54
Views:
689
Email this article 